These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 34092969)

  • 1. Open reading frame 3 protein of hepatitis E virus: Multi-function protein with endless potential.
    Yang YL; Nan YC
    World J Gastroenterol; 2021 May; 27(20):2458-2473. PubMed ID: 34092969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional ORF3 protein of hepatitis E virus.
    Li X; Sun X; Pinpin J; Zhao Q; Sun Y
    J Med Virol; 2024 Jun; 96(6):e29691. PubMed ID: 38783788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine Development against Zoonotic Hepatitis E Virus: Open Questions and Remaining Challenges.
    Nan Y; Wu C; Zhao Q; Sun Y; Zhang YJ; Zhou EM
    Front Microbiol; 2018; 9():266. PubMed ID: 29520257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Viral ORF3 Protein Is Required for Hepatitis E Virus Apical Release and Efficient Growth in Polarized Hepatocytes and Humanized Mice.
    Sari G; Zhu J; Ambardekar C; Yin X; Boonstra A; Feng Z; Vanwolleghem T
    J Virol; 2021 Nov; 95(23):e0058521. PubMed ID: 34523963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Hepatitis E Virus Open Reading Frame 2 Protein: Beyond Viral Capsid.
    Zhou Z; Xie Y; Wu C; Nan Y
    Front Microbiol; 2021; 12():739124. PubMed ID: 34690982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis E virus ORF3 protein hijacking thioredoxin domain-containing protein 5 (TXNDC5) for its stability to promote viral particle release.
    Sheng Y; Deng Y; Li X; Ji P; Sun X; Liu B; Zhu J; Zhao J; Nan Y; Zhou E-M; Hiscox JA; Stewart JP; Sun Y; Zhao Q
    J Virol; 2024 Apr; 98(4):e0164923. PubMed ID: 38548704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient formation and maintenance of humoral and CD4 T-cell immunity targeting the viral capsid in acute-resolving hepatitis E infection.
    Csernalabics B; Marinescu MS; Maurer L; Kelsch L; Werner J; Baumann K; Zoldan K; Panning M; Reuken P; Bruns T; Bengsch B; Neumann-Haefelin C; Hofmann M; Thimme R; Dao Thi VL; Boettler T
    J Hepatol; 2024 Apr; 80(4):564-575. PubMed ID: 38154741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research progress in the etiology of hepatitis type E virus].
    Xiong XY; Liu X; Yin X
    Zhonghua Gan Zang Bing Za Zhi; 2023 May; 31(5):460-465. PubMed ID: 37365020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on hepatitis E virology: Implications for clinical practice.
    Debing Y; Moradpour D; Neyts J; Gouttenoire J
    J Hepatol; 2016 Jul; 65(1):200-212. PubMed ID: 26966047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in the Production of Virus-Like Particles for Vaccination against Hepatitis E Virus.
    Mazalovska M; Kouokam JC
    Viruses; 2020 Jul; 12(8):. PubMed ID: 32751441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural aspects of hepatitis E virus.
    Cancela F; Noceti O; Arbiza J; Mirazo S
    Arch Virol; 2022 Dec; 167(12):2457-2481. PubMed ID: 36098802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replacement of the hepatitis E virus ORF3 protein PxxP motif with heterologous late domain motifs affects virus release via interaction with TSG101.
    Kenney SP; Wentworth JL; Heffron CL; Meng XJ
    Virology; 2015 Dec; 486():198-208. PubMed ID: 26457367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and molecular biology of hepatitis E virus.
    Wang B; Meng XJ
    Comput Struct Biotechnol J; 2021; 19():1907-1916. PubMed ID: 33995894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis E Virus Replication.
    LeDesma R; Nimgaonkar I; Ploss A
    Viruses; 2019 Aug; 11(8):. PubMed ID: 31390784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphogenesis of Hepatitis E Virus.
    Liu X; Qi S; Yin X
    Adv Exp Med Biol; 2023; 1417():159-169. PubMed ID: 37223865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the Quasi-Enveloped Hepatitis E Virus Particles Released by the Cellular Exosomal Pathway.
    Nagashima S; Takahashi M; Kobayashi T; ; Nishizawa T; Nishiyama T; Primadharsini PP; Okamoto H
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of Hepatitis E Virus Anti-ORF3 Antibodies from Systemic Administration of a Muscle-Specific Adeno-Associated Virus (AAV) Vector.
    Maurer L; El Andari J; Rapti K; Spreyer L; Steinmann E; Grimm D; Dao Thi VL
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Culture systems for hepatitis E virus.
    Okamoto H
    J Gastroenterol; 2013 Feb; 48(2):147-58. PubMed ID: 23104469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ORF3 protein of hepatitis E virus is essential for virion release from infected cells.
    Yamada K; Takahashi M; Hoshino Y; Takahashi H; Ichiyama K; Nagashima S; Tanaka T; Okamoto H
    J Gen Virol; 2009 Aug; 90(Pt 8):1880-1891. PubMed ID: 19339479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel multi-epitope peptide vaccine candidate targeting hepatitis E virus: An in silico approach.
    Kumar A; Sahu U; Agnihotri G; Dixit A; Khare P
    J Viral Hepat; 2024 Aug; 31(8):446-456. PubMed ID: 38727597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.